Decent whack of volume coming thru the last few days, strength in the Bg, A break n hold thru 34 is key here. Pnf D target 0.082
bought this off the chart. Biotech so high risk play. Chart super.
Cheap MC, Patent secured today, volume in with buyers stepping up. Re-rating. BIOSHARE mentioned that PAB could be takeover before clinical trials due to interest in this technology. As always DYOR
PAB is looking strong with a patent being granted for its PAT-DX1 and PAT-DX3 use on cancer. If it is able to close above 1.8c today, watch for quick movement to 2.2c
Going to take a punt on PAB for a monthly competition. Buyer be very beware. Reasons on chart.